EG 427 raises €27 million in successful Series B co-led by Andera Partners and Bpifrance to finance on-going clinical study and platform development

February 20, 2025
  • Specialist fund SCI Ventures, backed by major spinal cord injury foundations, together with existing investors, also participated in this round
  • Proceeds will finance phase 1b/2a study of EG110A through safety and early efficacy results
  • Opens way for clinical development across multiple medically important neuro-urology pathologies
  • Funding will also support the company’s early-stage pipeline based on its proprietary HERMES vector technology platform.

Read the full Press release in English or in French

< back

Recent posts

×

By clicking Consent, you accept the saving of all cookie data on your device. If you click Denied, only the data necessary for the website to function is saved. More information about cookies in the privacy policy.

settings Reject I agree
×

Essential Cookies

These cookies are necessary for the website to function and cannot be turned off. They are used, for example, to maintain the contents of the user's basket. You can set your browser to block these cookies, but then the website will not function prope

Always active

Analytical cookies

These cookies allow you to count visits and traffic sources. Thanks to these files, it is known which pages are more popular and how the website visitors navigate. All information these cookies collect is anonymous.